Original Research Articles
Download PDF (102.84 KB)
Journal of Structural Heart Disease, May 2015, Volume 1, Issue 1:5-8
DOI: 10.12945/j.jshd.2015.00010-14
Building a Structural Heart Disease Team: How to Integrate People
John M. Lasala, MD, PhD, Alejandro Aquino, MD
Barnes Jewish Hospital at Washington University School of Medicine, St. Louis, Missouri, USA
Abstract
Although the field of structural heart disease interven- tion is by no means a nascent one, it has undergone an unprecedented period of growth and organization over the past decade. The long-established stalwarts of aortic and mitral valvuloplasty have been joined by newer techniques including shunt (ASD/PFO) closure, transcatheter aortic valve replacement (TAVR), tran- scatheter pulmonary valve therapy, and mitral valve repair (MitraClip). As this field continues to unify, the expectation is that it will only grow. The prevalence of aortic and mitral valve disease is expected to increase as the population ages. This fact and the inevitable broadened commercial availability of these proce- dures will drive the number of structural procedures upwards. As an illustrative example, it is postulated that by 2015 the number of TAVR procedures will reach 25,000 per year.
Cite this article as: Lasala JM, Aquino A. Building a Structural Heart Disease Team: How to Integrate People. Structural Heart Disease 2015;1(1):5-8. DOI: 10.12945/j.jshd.2015.00010-14
All comments will be screened and reviewed before posting. Statements, opinions, and results of studies published in Journal of Structural Heart Disease are those of the authors and do not reflect the policy or position of The Journal and Science International and the Editorial Board and provides no warranty as to their accuracy or reliability. Material is copyrighted and owned by Science International and cannot be used without expressed permission.
Original Research Articles
Journal of Structural Heart Disease, May 2015, Volume 1, Issue 1:5-8
DOI: 10.12945/j.jshd.2015.00010-14
Building a Structural Heart Disease Team: How to Integrate People
John M. Lasala, MD, PhD, Alejandro Aquino, MD
Barnes Jewish Hospital at Washington University School of Medicine, St. Louis, Missouri, USA
Abstract
Although the field of structural heart disease interven- tion is by no means a nascent one, it has undergone an unprecedented period of growth and organization over the past decade. The long-established stalwarts of aortic and mitral valvuloplasty have been joined by newer techniques including shunt (ASD/PFO) closure, transcatheter aortic valve replacement (TAVR), tran- scatheter pulmonary valve therapy, and mitral valve repair (MitraClip). As this field continues to unify, the expectation is that it will only grow. The prevalence of aortic and mitral valve disease is expected to increase as the population ages. This fact and the inevitable broadened commercial availability of these proce- dures will drive the number of structural procedures upwards. As an illustrative example, it is postulated that by 2015 the number of TAVR procedures will reach 25,000 per year.
PDF
Mobile-ready Flipbook
Cite this article as: Lasala JM, Aquino A. Building a Structural Heart Disease Team: How to Integrate People. Structural Heart Disease 2015;1(1):5-8. DOI: 10.12945/j.jshd.2015.00010-14
You must be registered and logged in to leave comments.
There have been no comments posted yet
Ask a question (publicly)
Board